Harrow Inc (NASDAQ:HROW)
| 9.81 Delayed Data As of Dec 08 |  +0.15 / +1.56%Today’s Change | 7.60 Today|||52-Week Range 28.25 | -33.54% Year-to-Date |
Latest HROW News | Press Releases
No recent news for Harrow Inc.
Today’s Trading
| Previous close | 9.64 |
| Today’s open | 9.69 |
| Day’s range | 9.62 - 9.89 |
| Volume | 484,133 |
| Average volume (3 months) | 623,945 |
| Market cap | $343.8M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +25.72% |
| Earnings growth (this year) | +15.95% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +22.24% |
| P/E ratio | NM |
| Price/Sales | 4.58 |
| Price/Book | 10.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABUSArbutus Biopharma Co... | -0.01 | -0.48% |
| ---- | ||
| ORTXOrchard Therapeutics... | -0.01 | -0.06% |
| ---- |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | March 7, 2024 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $88.6M |
| Annual profit (last year) | -$14.1M |
| Net profit margin | -15.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
